Central regions | Finance, business

Russia’s RVC publishes 19 exits in 2018

5 Feb '19
RVC, Russia’s national fund of funds for innovation, has unveiled its 2018 operation results. For example, last year the sovereign fund approved a total of $30.8m in investments for 30 portfolio companies, a 40% increase from its 2017 investments (which totaled $21.5m in 24 portfolio companies).

In 2018, RVC made 19 exits from their portfolio companies worth a total of $26m (from six the year before). In 18 of these, the government investor ended up in the black.

For example, in September 2018 RBV Capital, a VC fund set up jointly by RVC and R-Pharm, sold its portfolio company, botulinum toxin (BTX) developer Bonti, to Allergan, an Irish pharmaceutical giant. The Irish paid an initial amount of $195m.
Publish in Twitter
Write to Facebook
Google Buzz
Write to LiveJournal
Show in MM
Share MK
COMMENT ON THIS STORY
Find Related Content

Locations:

Tags: RBV Capital (2) / RVC (169) / exits (0) /

Latest News: Central regions
23 Apr '19 | Finance, business | Technology & innovation
22 Apr '19 | Finance, business | Retail, FMCG
16 Apr '19 | Technology & innovation
11 Apr '19 | Finance, business
 

Feature stories

4 Apr '19
Russian scientists have come up with what they say is...
29 Jan '19
Russian biologists and biophysicists have developed...
2 Nov '18
Drawing upon in-depth interviews, the book channels...
Search (News archive - 21342)
Advertising
Venture_Russia_2018
Advertising
NATT
Advertising
Independent Software Developers Forum
Advertising
Marchmont News

Latest News

24 Apr '19
Data MATRIX, a St. Petersburg-based IT developer, has...
23 Apr '19
Steel magnate Alexey Mordashov has taken over a...
22 Apr '19
First Data, a young Russian company, is developing a...

Most read stories from last week

23 Apr '19
Steel magnate Alexey Mordashov has taken over a...
22 Apr '19
First Data, a young Russian company, is developing a...
24 Apr '19
Data MATRIX, a St. Petersburg-based IT developer, has...